Loncastuximab Tesirine and Venetoclax for Relapsed/ Refractory Non-Hodgkin Lymphoma
Clinical trial NCT05053659 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05053659
- Sponsor
- Paolo Caimi, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-20
- Primary completion
- 2026-11-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.